Serum Albumin as a Prognostic Marker for Serious Non-AIDS Endpoints in the Strategic Timing of Antiretroviral Treatment (START) Study.
J Infect Dis
; 217(3): 405-412, 2018 01 17.
Article
en En
| MEDLINE
| ID: mdl-29244111
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Biomarcadores
/
Infecciones por VIH
/
Enfermedades no Transmisibles
/
Albúmina Sérica Humana
Tipo de estudio:
Clinical_trials
/
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Año:
2018
Tipo del documento:
Article